Source: Eur Respir J 2016; 47: 327-330



Rating:

Share or cite this content

Citations should be made in the following way:
Teepe Jolien, Little Paul, Elshof Nori, Broekhuizen Berna D.L., Moore Michael, Stuart Beth, Butler Chris C., Hood Kerenza, Ieven Margareta, Coenen Samuel, Goossens Herman, Verheij Theo J.M.. Amoxicillin for clinically unsuspected pneumonia in primary care: subgroup analysis. Eur Respir J 2016; 47: 327-330

Member's Comments

No comment yet.

Related content which might interest you: Management of community-acquired pneumonia in primary care: an observational study Source: International Congress 2019 – Treatment of airway diseases in primary care Year: 2019 A retrospective survival analysis of nursing and healthcare associated pneumonia in patients with resistant pathogens Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia Year: 2018 Microbiological study of community acquired pneumonia versus nosocomial pneumonia in pediatric age group Source: Eur Respir J 2004; 24: Suppl. 48, 714s Year: 2004 Health care associated pneumonia versus community acquired pneumonia: Comparison of etiology, treatment and prognosis Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012 Pleural effusion predicts poor outcomes in hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008 Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009 Invasive procedures and etiological diagnosis in severe pneumonia: A case study of 20 patients Source: Eur Respir J 2003; 22: Suppl. 45, 544s Year: 2003 A study of etiological and clinical profile of community acquired pneumonia in a tertiary care hospital in Western India Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013 A prediction rule to identify allocation of inpatient care in community-acquired pneumonia Source: Eur Respir J 2003; 21: 695-701 Year: 2003 Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted into secondary hospitals Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Model of diagnosis scoring, clinical and molecular profile of invasive pulmonary aspergillosis (IPA) in ICU patients Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 Cost-efficacy analysis of cefixime switch therapy in the treatment of community acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 350s Year: 2006 Factors related to obtain an etiological diagnosis in community acquired pneumonia (CAP) Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 Thrombocytosis predicts poor outcomes in patients with community-acquired pneumonia: results from the CAPO international cohort study Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008 Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis Source: Eur Respir J 2008; 31: 1068-1076 Year: 2008 The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia Year: 2007 Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis Source: Eur Respir J 2011; 37: 858-864 Year: 2011 Significant decrease in long-term survival for hospitalised patients with community-acquired pneumonia (CAP): results from the community-acquired pneumonia organisation (CAPO) international cohort study Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009 The APO-audit in the primary health care of archangelsk region: the way to the effective therapy of community-acquired respiratory infections Source: Annual Congress 2009 - Diagnostic strategies in primary respiratory care Year: 2009 Alternate diagnosis in clinically diagnosed pulmonary tuberculosis patients treated at tertiary care hospital in a high TB burden country Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations Year: 2020